| Line 47: |
Line 47: |
| | | | |
| | Incorporation of BrdU makes cells more sensitive to radiation damage. | | Incorporation of BrdU makes cells more sensitive to radiation damage. |
| | + | |
| | + | =Pharmacokinetics= |
| | + | |
| | + | Papers to look up re: pharmacokinetics |
| | + | |
| | + | 1: |
| | + | The toxic effect of 5-bromodeoxyuridine on cultured epithelial cells. |
| | + | LITTLEFIELD JW, GOULD EA. |
| | + | J Biol Chem. 1960 Apr;235:1129-33. No abstract available. |
| | + | PMID 14417553 [PubMed - OLDMEDLINE] |
| | + | |
| | + | Related Articles Free article at journal site |
| | + | |
| | + | 2: |
| | + | Relative stability to thermal denaturation of deoxyribonucleic acid (DNA) preparations containing bromodeoxyuridine. |
| | + | KIT S, HSU TC. |
| | + | Biochem Biophys Res Commun. 1961 Jun 2;5:120-4. No abstract available. |
| | + | PMID 13756434 |
| | + | |
| | + | 3: |
| | + | Quantitative studies of incorporation of exogenous thymidine and 5-bromodeoxyuridine into deoxyribonucleic acid of mammalian cells in vitro. |
| | + | KRISS JP, REVESZ L. |
| | + | Cancer Res. 1961 Oct;21:1141-7. No abstract available. |
| | + | PMID 14459708 |
| | + | |
| | + | 4: |
| | + | Incorporation of unnatural pyrimidine bases into deoxyribonucleic acid of mammalian cells. |
| | + | EIDINOFF ML, CHEONG L, RICH MA. |
| | + | Science. 1959 Jun 5;129(3362):1550-1. |
| | + | PMID 13658990 |
| | + | |
| | + | 5: |
| | + | The fate of 5-bromodeoxyuridine, 5-bromodeoxycytidine, and 5-iododeoxycytidine in man. |
| | + | KRISS JP, MARUYAMA Y, TUNG LA, BOND SB, REVESZ L. |
| | + | Cancer Res. 1963 Feb;23:260-8. No abstract available. |
| | + | PMID 14035826 Free article at journal site |
| | + | |
| | + | 6: |
| | + | Effect of 5-bromodeoxyuridine incorporation on survival of cultured mammalian cells. |
| | + | HAKALA MT. |
| | + | Biochim Biophys Acta. 1962 Nov 26;61:815-23. No abstract available. |
| | + | PMID 13952011 [PubMed - OLDMEDLINE] |
| | + | |
| | + | Related Articles |
| | + | |
| | + | 7: |
| | + | A chromosome study of radiation sensitization by 5-bromodeoxyuridine. |
| | + | SOMERS CE, HUMPHREY RM. |
| | + | Exp Cell Res. 1963 Mar;30:208-17. No abstract available. |
| | + | PMID 13978156 |
| | + | |
| | + | 8: |
| | + | Radiosensitization of a mammalian cell line with 5-bromodeoxyuridine. |
| | + | DELIHAS N, RICH MA, EIDINOFF ML. |
| | + | Radiat Res. 1962 Oct;17:479-91. No abstract available. |
| | + | PMID 14026711 [PubMed - OLDMEDLINE] |
| | + | |
| | + | Related Articles |
| | + | |
| | + | 9: |
| | + | The distribution and fate of bromodeoxyuridine and bromodeoxycytidine in the mouse and rat. |
| | + | KRISS JP, REVESZ L. |
| | + | Cancer Res. 1962 Feb;22:254-65. No abstract available. |
| | + | PMID 14459709 Free article at journal site |
| | + | |
| | + | 10: |
| | + | Increase in radiosensitivity to ionizing radiation related to replacement of thymidine in mammalian cells with 5-bromodeoxyuridine. |
| | + | Dewey WC, Humphrey RM. |
| | + | Radiat Res. 1965 Dec;26(4):538-53. No abstract available. |
| | + | PMID 5849707 |
| | + | |
| | + | 11: |
| | + | Structures of 5-bromodeoxyuridine and 5-bromouridine. |
| | + | Iball J, Morgan CH, Wilson HR. |
| | + | Nature. 1966 Mar 19;209(5029):1230-2. No abstract available. |
| | + | PMID 5956313 |
| | + | |
| | + | 12: |
| | + | Intra-arterial 5-bromodeoxyuridine and x-ray therapy. |
| | + | Bagshaw MA, Doggett RL, Smith KC, Kaplan HS, Nelsen TS. |
| | + | Am J Roentgenol Radium Ther Nucl Med. 1967 Apr;99(4):886-94. No abstract available. |
| | + | PMID 6021392 |
| | + | |
| | + | 13: |
| | + | Theoretical evaluation of a limitation in the use of pyrimidine analogs in radiation therapy. |
| | + | Suit HD. |
| | + | Radiology. 1966 Dec;87(6):1065-8 passim. No abstract available. |
| | + | PMID 5926229 |
| | + | |
| | + | 14: |
| | + | Comparative aspects of the pharmacology of the antimetabolites. |
| | + | Karnofsky DA, Young CW. |
| | + | Fed Proc. 1967 Jul-Aug;26(4):1139-45. No abstract available. |
| | + | PMID 4226285 |
| | + | |
| | + | 15: |
| | + | Loss of labelled DNA from rat brain following injections of precursors with high specific radioactivity. II. DNA labelled with 5-[131I]iodo-2'-deoxyuridine and 5-[82Br]bromo-2'-deoxyuridine. |
| | + | Merits I, Cain JC. |
| | + | Biochim Biophys Acta. 1970;209(2):327-38. No abstract available. |
| | + | PMID 5453521 |
| | + | |
| | + | 16: |
| | + | The turnover of isotopically labelled DNA in vivo in developing, adult and Scrapie-affected mouse brain. |
| | + | Kimberlin RH, Shirt DB, Collis SC. |
| | + | J Neurochem. 1974 Jul;23(1):241-8. No abstract available. |
| | + | PMID 4859554 |
| | + | |
| | + | 17: |
| | + | Comparison of bromodeoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumors. |
| | + | Nagashima T, Hoshino T, Cho KG, Senegor M, Waldman F, Nomura K. |
| | + | J Neurosurg. 1988 Mar;68(3):388-92. |
| | + | PMID 3278075 |
| | + | |
| | + | 18: |
| | + | Improvement of the bioavailability of the anti-herpes virus agent BVDU by use of 5'-O-alkoxycarbonyl derivatives with increased metabolic stability. |
| | + | Boyd MR, Cole M, Harnden MR, Luk K, Rush MA, Sutton D, Hodge RA. |
| | + | J Antimicrob Chemother. 1986 Oct;18 Suppl B:207-13. |
| | + | PMID 3793660 |
| | + | |
| | + | 19: |
| | + | Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. |
| | + | Hoshino T, Nagashima T, Murovic J, Levin EM, Levin VA, Rupp SM. |
| | + | Cytometry. 1985 Nov;6(6):627-32. |
| | + | PMID 2998714 |
| | + | |
| | + | 20: |
| | + | Bioavailability of bromodeoxyuridine in dogs and toxicity in rats. |
| | + | Phuphanich S, Levin VA. |
| | + | Cancer Res. 1985 May;45(5):2387-9. No abstract available. |
| | + | PMID 3986781 Free article at journal site |
| | + | |
| | + | 21: |
| | + | Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors. |
| | + | Russo A, Gianni L, Kinsella TJ, Klecker RW Jr, Jenkins J, Rowland J, Glatstein E, Mitchell JB, Collins J, Myers C. |
| | + | Cancer Res. 1984 Apr;44(4):1702-5. |
| | + | PMID 6704976 Free article at journal site |
| | + | |
| | + | 22: |
| | + | Incorporation and persistence of 5-bromodeoxyuridine in newborn rat tissue DNA. |
| | + | Likhachev AJ, Tomatis L, Margison GP. |
| | + | Chem Biol Interact. 1983 Aug 15;46(1):31-8. |
| | + | PMID 6616707 |
| | + | |
| | + | 23: |
| | + | Incorporation of 5-bromodeoxyuridine into DNA in newborn rat tissues. |
| | + | Margison GP, Likhachev AJ, Tomatis L. |
| | + | Chem Biol Interact. 1980 Jun;30(3):297-303. |
| | + | PMID 7379209 |
| | + | |
| | + | 24: |
| | + | Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--III. 2'-[82Br]-bromo-2'-deoxyuridine. |
| | + | Lee YW, Knaus EE, Wiebe LI. |
| | + | Int J Nucl Med Biol. 1979;6(2):109-112. No abstract available. |
| | + | PMID 113355 |
| | + | |
| | + | 25: |
| | + | Bromodeoxyuridine incorporation into DNA of human leukemia cells is not concentration dependent. |
| | + | Powell BL, Gregory BW, Kute TE, Morgan TM, Lyerly ES, Capizzi RL. |
| | + | Cytometry. 1990;11(3):438-41. |
| | + | PMID 2340778 |
| | + | |
| | + | 26: |
| | + | Immunocytochemical detection of 5'-bromodeoxyuridine incorporation in the central nervous system of the mouse. |
| | + | del Rio JA, Soriano E. |
| | + | Brain Res Dev Brain Res. 1989 Oct 1;49(2):311-7. |
| | + | PMID 2805336 |
| | + | |
| | + | 27: |
| | + | In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67. |
| | + | Morimura T, Kitz K, Budka H. |
| | + | Acta Neuropathol. 1989;77(3):276-82. |
| | + | PMID 2922990 |
| | + | |
| | + | 28: |
| | + | Steady-state arterial and hepatic venous plasma concentrations of 5-bromo-2'-deoxyuridine and 5-iodo-2'-deoxyuridine in animals--drugs which are subject to both splanchnic and extra-splanchnic elimination. |
| | + | Wagner JG, Stetson PL, Knol JA, Andrews JC, Walker-Andrews S, Knutsen CA, Johnson N, Prieskorn D, Terrio P, Yang Z, et al. |
| | + | Sel Cancer Ther. 1989 Winter;5(4):193-203. |
| | + | PMID 2623384 |
| | + | |
| | + | 29: |
| | + | Tissue-specific pharmacodynamics of 5-bromo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits. |
| | + | Stetson PL, Maybaum J, Wagner JG, Averill DR, Wollner IS, Knol JA, Johnson NJ, Yang ZM, Preiskorn D, Smith P, et al. |
| | + | Cancer Res. 1988 Dec 1;48(23):6900-5. |
| | + | PMID 3180098 Free article at journal site |
| | + | |
| | + | 30: |
| | + | Persistence of 5-bromo-2'-deoxyuridine in tissues of rats after exposure in early life. |
| | + | Ward JM, Henneman JR, Osipova GYu, Anisimov VN. |
| | + | Toxicology. 1991;70(3):345-52. |
| | + | PMID 1771641 |
| | + | |
| | + | 31: |
| | + | cis-trans-isomerization of [E]-5-(2-bromovinyl)-2,2'-anhydrouridine in vivo in rats. |
| | + | Szinai I, Veres Z, Szabolcs A, Gács-Baitz E, Ujszászy K, Dénes G. |
| | + | Xenobiotica. 1991 Mar;21(3):359-69. |
| | + | PMID 1650515 |
| | + | |
| | + | 32: |
| | + | The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure. |
| | + | Lawrence TS, Davis MA, Maybaum J, Stetson PL, Ensminger WD. |
| | + | Int J Radiat Oncol Biol Phys. 1990 Jun;18(6):1393-8. |
| | + | PMID 2370189 |
| | + | |
| | + | 33: |
| | + | Cyclization-activated prodrugs. Basic esters of 5-bromo-2'-deoxyuridine. |
| | + | Saari WS, Schwering JE, Lyle PA, Smith SJ, Engelhardt EL. |
| | + | J Med Chem. 1990 Sep;33(9):2590-5. |
| | + | PMID 2391697 |
| | + | |
| | + | 34: |
| | + | Effect of lithium on incorporation of bromodeoxyuridine and tritiated thymidine into human parathyroid cells. |
| | + | Saxe A, Gibson G. |
| | + | Arch Surg. 1993 Aug;128(8):865-9. |
| | + | PMID 8343059 |
| | + | |
| | + | 35: |
| | + | Evaluation of a new lipophilic prodrug 3', 5'-dioctanoyl-5-bromodeoxyuridine (BrdU-C8) suspended in Lipiodol as a radiosensitizer for the treatment of AH136B tumor. |
| | + | Ohara C, Beppu T, Yamaguchi Y, Masuda Y, Fukushima S, Kawaguchi T, Ogawa M. |
| | + | Anticancer Res. 1993 May-Jun;13(3):655-60. |
| | + | PMID 8391245 |
| | + | |
| | + | 36: |
| | + | Measurement of incorporation of bromodeoxyuridine into DNA by high performance liquid chromatography using a novel fluorescent labelling technique. |
| | + | Stratford MR, Dennis MF. |
| | + | Int J Radiat Oncol Biol Phys. 1992;22(3):485-7. |
| | + | PMID 1735684 |
| | + | |
| | + | 37: |
| | + | Kinetics of bromodeoxyuridine elimination from human colon cancer cells in vitro and in vivo. |
| | + | Lawrence TS, Davis MA, Stetson PL, Maybaum J, Ensminger WD. |
| | + | Cancer Res. 1994 Jun 1;54(11):2964-8. |
| | + | PMID 8187082 Free article at journal site |
| | + | |
| | + | 38: |
| | + | Differential expressions of the topoisomerase II alpha and II beta mRNAs in developing rat brain. |
| | + | Watanabe M, Tsutsui K, Tsutsui K, Inoue Y. |
| | + | Neurosci Res. 1994 Feb;19(1):51-7. |
| | + | PMID 8008235 |
| | + | |
| | + | 39: |
| | + | Preparation, characterization and release of microencapsulated bromodeoxyuridine. |
| | + | Maysinger D, Filipović-Grcić J, Alebić-Kolbah T. |
| | + | Life Sci. 1994;54(1):27-34. |
| | + | PMID 8255166 |
| | + | |
| | + | 40: |
| | + | Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme. |
| | + | Onda K, Davis RL, Wilson CB, Hoshino T. |
| | + | Acta Neuropathol. 1994;87(6):586-93. |
| | + | PMID 8091951 |
| | + | |
| | + | 41: |
| | + | The application of 5-bromodeoxyuridine in the management of CNS tumors. |
| | + | Freese A, O'Rourke D, Judy K, O'Connor MJ. |
| | + | J Neurooncol. 1994;20(1):81-95. Review. |
| | + | PMID 7807187 |
| | + | |
| | + | 42: |
| | + | Comparison of bromodeoxyuridine uptake and MIB 1 immunoreactivity in medulloblastomas determined with single and double immunohistochemical staining methods. |
| | + | Onda K, Davis RL, Edwards MS. |
| | + | J Neurooncol. 1996 Aug;29(2):129-36. |
| | + | PMID 8858517 |
| | + | |
| | + | 43: |
| | + | Incorporation of 5-iodo-2'-deoxyuridine and 5-bromo-2'-deoxyuridine into rodent DNA as determined by neutron activation analysis. |
| | + | Kitchin KT, Brown JL. |
| | + | Anal Biochem. 1995 Aug 10;229(2):180-7. |
| | + | PMID 7485970 |
| | + | |
| | + | 44: |
| | + | Pharmacokinetics and bioavailability of 5-ethyl-2'-deoxyuridine and its novel (5R,6R)-5-bromo-6-ethoxy-5,6-dihydro prodrugs in mice. |
| | + | Cheraghali AM, Kumar R, Knaus EE, Wiebe LI. |
| | + | Drug Metab Dispos. 1995 Feb;23(2):223-6. |
| | + | PMID 7736915 |
| | + | |
| | + | 45: |
| | + | Long-term oral application of 5-bromo-2-deoxyuridine does not reliably label proliferating immune cells in the LEW rat. |
| | + | Jecker P, Beuleke A, Dressendörfer I, Pabst R, Westermann J. |
| | + | J Histochem Cytochem. 1997 Mar;45(3):393-401. |
| | + | PMID 9071321 Free article at journal site |
| | + | |
| | + | 46: |
| | + | Fluorescein-labeled tyramide strongly enhances the detection of low bromodeoxyuridine incorporation levels. |
| | + | Van Heusden J, de Jong P, Ramaekers F, Bruwiere H, Borgers M, Smets G. |
| | + | J Histochem Cytochem. 1997 Feb;45(2):315-9. |
| | + | PMID 9016320 Free article at journal site |
| | + | |
| | + | 47: |
| | + | Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions. |
| | + | Kuan HY, Smith DE, Ensmiger WD, Knol JA, DeRemer SJ, Yang Z, Stetson PL. |
| | + | Cancer Res. 1996 Oct 15;56(20):4724-7. |
| | + | PMID 8840990 Free article at journal site |
| | + | |
| | + | 48: |
| | + | Bromodeoxyuridine uptake by early liver metastases in rats: a comparison of the hepatic artery and portal vein infusion routes. |
| | + | Ishida H, Iwama T, Yoshinaga K, Gonda T, Idezuki Y. |
| | + | Surg Today. 1998;28(8):822-9. |
| | + | PMID 9719004 |
| | + | |
| | + | 49: |
| | + | Assessment of correlation between skin target site free drug concentration and the in vivo topical antiviral efficacy in hairless mice for (E)-5-(2-bromovinyl)-2'-deoxyuridine and acyclovir formulations. |
| | + | Afouna MI, Mehta SC, Ghanem AH, Higuchi WI, Kern ER, De Clercq E, El-Shattawy HH. |
| | + | J Pharm Sci. 1998 Aug;87(8):917-21. |
| | + | PMID 9687333 |
| | + | |
| | + | 50: |
| | + | Changes in cell-cycle kinetics during the development and evolution of primate neocortex. |
| | + | Kornack DR, Rakic P. |
| | + | Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1242-6. |
| | + | PMID 9448316 Free article in PMC | at journal site |
| | + | |
| | + | 51: |
| | + | Bromodeoxyuridine alternating with radiation for advanced uterine cervix cancer: a phase I and drug incorporation study. |
| | + | Eisbruch A, Robertson JM, Johnston CM, Tworek J, Reynolds KR, Roberts JA, Lawrence TS. |
| | + | J Clin Oncol. 1999 Jan;17(1):31-40. |
| | + | PMID 10458215 |
| | + | |
| | + | 52: |
| | + | Determination of (E)-5-(2-bromovinyl)-2'-deoxyuridine in plasma and urine by capillary electrophoresis. |
| | + | Olgemöller J, Hempel G, Boos J, Blaschke G. |
| | + | J Chromatogr B Biomed Sci Appl. 1999 Apr 16;726(1-2):261-8. |
| | + | PMID 10348194 |
| | + | |
| | + | 53: |
| | + | Elimination of nonspecific radioactivity from [76Br]bromide in PET study with [76Br]bromodeoxyuridine. |
| | + | Lu L, Bergström M, Fasth KJ, Wu F, Eriksson B, Långström B. |
| | + | Nucl Med Biol. 1999 Oct;26(7):795-802. |
| | + | PMID 10628559 |
| | + | |
| | + | 54: |
| | + | [76Br]Bromodeoxyuridine, a potential tracer for the measurement of cell proliferation by positron emission tomography, in vitro and in vivo studies in mice. |
| | + | Ryser JE, Bläuenstein P, Rémy N, Weinreich R, Hasler PH, Novak-Hofer I, Schubiger PA. |
| | + | Nucl Med Biol. 1999 Aug;26(6):673-9. |
| | + | PMID 10587106 |
| | + | |
| | + | 55: |
| | + | Analysis of 76Br-BrdU in DNA of brain tumors after a PET study does not support its use as a proliferation marker. |
| | + | Gudjonssona O, Bergström M, Kristjansson S, Wu F, Nyberg G, Fasth KJ, Långström B. |
| | + | Nucl Med Biol. 2001 Jan;28(1):59-65. |
| | + | PMID 11182565 |
| | + | |
| | + | 56: |
| | + | [76Br]Bromodeoxyuridine PET in tumor-bearing animals. |
| | + | Gardelle O, Roelcke U, Vontobel P, Crompton NE, Guenther I, Bläuenstein P, Schubiger AP, Blattmann H, Ryser JE, Leenders KL, Kaser-Hotz B. |
| | + | Nucl Med Biol. 2001 Jan;28(1):51-7. |
| | + | PMID 11182564 |
| | + | |
| | + | 57: |
| | + | Use of 5-[(76)Br]bromo-2'-fluoro-2'-deoxyuridine as a ligand for tumour proliferation: validation in an animal tumour model. |
| | + | Borbath I, Grégoire V, Bergström M, Laryea D, Långström B, Pauwels S. |
| | + | Eur J Nucl Med Mol Imaging. 2002 Jan;29(1):19-27. Epub 2001 Nov 22. |
| | + | PMID 11807603 |
| | + | |
| | + | 58: |
| | + | A method for pulse and chase BrdU-labeling of early chick embryos. |
| | + | Hämmerle B, Tejedor FJ. |
| | + | J Neurosci Methods. 2002 Dec 31;122(1):59-64. |
| | + | PMID 12535764 |
| | + | |
| | + | 59: |
| | + | Label-retaining cells in the rat pancreas: location and differentiation potential in vitro. |
| | + | Duvillié B, Attali M, Aiello V, Quemeneur E, Scharfmann R. |
| | + | Diabetes. 2003 Aug;52(8):2035-42. |
| | + | PMID 12882920 Free article at journal site |
| | + | |
| | + | 60: |
| | + | Brivudine: a herpes virostatic with rapid antiviral activity and once-daily dosing. |
| | + | Rabasseda X. |
| | + | Drugs Today (Barc). 2003 May;39(5):359-71. Review. |
| | + | PMID 12861349 |
| | + | |
| | + | 61: |
| | + | Visualization of proliferating cells in the adult mammalian brain with the aid of ribonucleotide reductase. |
| | + | Zhu H, Wang ZY, Hansson HA. |
| | + | Brain Res. 2003 Jul 11;977(2):180-9. |
| | + | PMID 12834878 |
| | + | |
| | + | 62: |
| | + | Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent. |
| | + | Kyle AH, Huxham LA, Baker JH, Burston HE, Minchinton AI. |
| | + | Cancer Res. 2003 Sep 15;63(18):5707-11. |
| | + | PMID 14522888 Free article at journal site |
| | + | |
| | + | 63: |
| | + | Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture. |
| | + | Kyle AH, Huxham LA, Chiam AS, Sim DH, Minchinton AI. |
| | + | Cancer Res. 2004 Sep 1;64(17):6304-9. |
| | + | PMID 15342419 Free article at journal site |
| | + | |
| | + | 64: |
| | + | Thymidine analogs are transferred from prelabeled donor to host cells in the central nervous system after transplantation: a word of caution. |
| | + | Burns TC, Ortiz-González XR, Gutiérrez-Pérez M, Keene CD, Sharda R, Demorest ZL, Jiang Y, Nelson-Holte M, Soriano M, Nakagawa Y, Luquin MR, Garcia-Verdugo JM, Prósper F, Low WC, Verfaillie CM. |
| | + | Stem Cells. 2006 Apr;24(4):1121-7. Epub 2005 Dec 22. |
| | + | PMID 16373692 Free article at journal site |
| | + | |
| | + | 65: |
| | + | Gadofluorine m uptake in stem cells as a new magnetic resonance imaging tracking method: an in vitro and in vivo study. |
| | + | Giesel FL, Stroick M, Griebe M, Tröster H, von der Lieth CW, Requardt M, Rius M, Essig M, Kauczor HU, Hennerici MG, Fatar M. |
| | + | Invest Radiol. 2006 Dec;41(12):868-73. |
| | + | PMID 17099425 |
| | + | |
| | + | 66: |
| | + | Ki-67 correlates with in vivo bromodeoxyuridine labeling index in operable breast cancer. |
| | + | Goodson WH, Moore DH, Waldman FM. |
| | + | J Clin Oncol. 2006 Aug 10;24(23):3809; author reply 3809. No abstract available. |
| | + | PMID 16896010 |
| | + | |
| | + | 67: |
| | + | An ELISA-based method for the quantification of incorporated BrdU as a measure of cell proliferation in vivo. |
| | + | Behl B, Klos M, Serr M, Ebert U, Janson B, Drescher K, Gross G, Schoemaker H. |
| | + | J Neurosci Methods. 2006 Nov 15;158(1):37-49. Epub 2006 Jun 15. |
| | + | PMID 16780957 |
| | + | |
| | + | 68: |
| | + | Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells. |
| | + | Fu L, Osuga Y, Morimoto C, Hirata T, Hirota Y, Yano T, Taketani Y. |
| | + | Fertil Steril. 2008 May;89(5 Suppl):1344-7. Epub 2007 May 23. |
| | + | PMID 17511992 |
| | + | |
| | + | 69: |
| | + | Bromodeoxyuridine labeling index as an indicator of early tumor response to preoperative radiotherapy in patients with rectal cancer. |
| | + | Gasinska A, Skolyszewski J, Popiela T, Richter P, Darasz Z, Nowak K, Niemiec J, Biesaga B, Adamczyk A, Bucki K, Malecki K, Reinfuss M, Kowalska T. |
| | + | J Gastrointest Surg. 2007 Apr;11(4):520-8. |
| | + | PMID 17436139 Free article in PMC | at journal site |
| | + | |
| | + | 70: |
| | + | The origin of deoxynucleosides in brain: implications for the study of neurogenesis and stem cell therapy. |
| | + | Spector R, Johanson CE. |
| | + | Pharm Res. 2007 May;24(5):859-67. Epub 2007 Mar 20. Review. |
| | + | PMID 17372683 |
| | | | |
| | [[Category:Flavor Preference]] | | [[Category:Flavor Preference]] |